A new scientific analysis of nearly 4,000 mutations deliberately engineered into the BRCA1 gene will immediately benefit people undergoing genetic testing for breast or ovarian cancer risk.
This KING5 video looks at a free home genetic test for women who are at risk for ovarian cancer is available through MAGENTA, which s short for MAking GENetic Testing Accessible
Not all cancer screenings are created equal.
A free home genetic test for women who are at risk for ovarian cancer is available through MAGENTA, which s short for MAking GENetic Testing Accessible.
In a study of 36 women – 16 diagnosed with ovarian cancer and a control group of 20 with no cancer diagnosis – nearly all of the women were found to carry cancer-associated gene mutations.
A national alliance of cancer-focused groups today announced the formation of a "dream team" dedicated to ovarian cancer research, and investment of $6 million over three years to pursue therapies.
Fifty-seven percent of physicians correctly assessed female patients’ risk for ovarian cancer and 62 percent correctly assessed their risk for colon cancer in a